Welcome to our dedicated page for Waldencast plc SEC filings (Ticker: WALDW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Waldencast plc (WALDW) SEC filings page on Stock Titan provides access to regulatory documents filed by this beauty and wellness operating platform as a foreign private issuer. Waldencast plc files annual reports on Form 20-F and furnishes current reports on Form 6-K under the Securities Exchange Act of 1934.
Available Form 6-K filings show how the company uses these reports to share business and regulatory developments. One Form 6-K indicates that Waldencast plc issued a press release describing strong progress on business priorities for a half-year period and initiatives to drive transformation, with the press release attached as an exhibit. Another Form 6-K states that the company announced FDA approval of Obagi® saypha® MagIQ™ Injectable Hyaluronic Acid Gel under the Obagi Medical brand, again with the related announcement attached as an exhibit.
On this page, users can review such Form 6-K submissions, which may include press releases and other materials related to the Obagi Medical and Milk Makeup segments. Because WALDW represents warrants of Waldencast plc, these filings help clarify the regulatory and business context of the underlying issuer.
Stock Titan enhances these filings with AI-powered summaries that explain the key points of each document in plain language. Users can quickly understand the focus of a Form 6-K, identify references to regulatory approvals or business priorities, and navigate to exhibits such as press releases. Real-time updates from EDGAR help ensure that new Waldencast plc filings, including future Form 20-F annual reports or additional Form 6-K current reports, are incorporated as they become available.